Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
64,770,635
-
Share change
-
+1,466,652
-
Total reported value
-
$3,674,886,472
-
Put/Call ratio
-
128%
-
Price per share
-
$56.76
-
Number of holders
-
308
-
Value change
-
+$86,998,145
-
Number of buys
-
158
-
Number of sells
-
134
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2018
As of 30 Sep 2018,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,770,635 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, JANUS HENDERSON GROUP PLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, Van Berkom & Associates Inc., and Standard Life Aberdeen plc.
This page lists
309
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.